Your Account
Mechanisms in B-Cell Neoplasia 1990
Workshop 1990 at the National Cancer Institute National Institutes of Health Bethesda, MD, USA, March 28–30,1990
(To see other currencies, click on price)
Paperback / softback
Add to basket  


Main description:

The eighth workshop in this series on Mechanisms in B-Cell Neoplasia 1990 was held in Wilson Hall at the National Institutes of Health, Bethesda, Maryland on March 28-30. Five major topics formed the basis for the discussions: 1) progress in experimental models of B-cell tumorigenesis, 2) the role of IL-6 in plasma cell tumor formation with particular emphasis on human myeloma, 3) immortaliza­ tion and regulation of mitosis in B-cells, 4) the mYQ gene in B-cell neoplasia, and 5) the role of EBV and other oncogenes in transforma­ tion of human B-Iymphocytes. A meeting on the Epidemiology of Myeloma was held at the N. I. H. on the preceding day, and many of those interested in the clinical aspects of myeloma were also participants at the workshop. Experimental Models of B-Cell Tumor Development We have seen in the last eight years the steady growth of model experimental systems, many of which have been designed to be counter­ parts of the major forms of human B cell tumors, e. g. , follicular lymphomas, Burkitt's lymphomas, acute B-cell leukemia and multiple myeloma. A variety of novel ways of inducing these tumors has been described. Advantage has been taken of the "experiments in nature" to identify critical genes that playa role in tumor pathogenesis. These genes have been identified by being near to viral insertion and chromosomal translocation sites, or by having been incorporated or transduced into a defective transforming retrovirus.


IL-6 in Multiple Myeloma.- IL-6 as a Growth Factor for Human Multiple Myeloma Cells -A Short Overview.- Interleukin 6 (IL-6) and Its Receptor (IL-6R) in Myeloma/Plasmacytoma. With 7 Figures.- Interleukin-6 is a Major Myeloma Cell Growth Factor In Vitro and In Vivo Especially in Patients with Terminal Disease. With 4 Figures.- Macrophages as an Important Source of Paracrine IL6 in Myeloma Bone Marrow. With 1 Figure.- Retroviral-Mediated Transfer of Interleukin-6 Into Hematopoietic Cells of Mice Results in a Syndrome Resembling Castleman’s Disease. With 3 Figures.- A Monoclonal Antibody Specific for the Murine IL-6-Receptor Inhibits the Growth of a Mouse Plasmacytoma In Vivo. With 3 Figures.- Production of IL-2 in CD25 Positive Malignant Lymphomas.- IL-6 Induces Hybridoma Cell Growth Through a Novel Signalling Pathway. With 4 Figures.- Selective Killing of IL6 Receptor Bearing Myeloma Cells Using Recombinant IL6-Pseudomonas Toxin. With 2 Figures.- In Vitro Culture of a Primary Plasmacytoma that has Retained Its Dependence on Pristane Conditioned Microenvironment for Growth. With 1 Figure.- Experimental Plasmacytomas and B-Cell Tumors.- Modulation of Growth and Differentiation of Murine Myeloma Cells by Immunoglobulin Binding Factors. With 3 Figures.- A New Cell Adhesion Mechanism Involving Hyaluronate and CD44. With 1 Figure.- The Activity of an ABL-MYC Retrovirus in Fibroblast Cell Lines and in Lymphocytes. With 3 Figure.- Plasmacytoma Induction in BALB/c6;15 ? DBA/2 Chimeras.With 4 figures.- Mouse Plasmacytoma Associated (MPC) T(15;16) Translocation Occurs Repeatedly in New MPC Induction System. With 8 Figures.- A Retrovirus Expressing v-abl and c-myc Induces Plasmacytomas in 100% of Adult Pristane-PrimedBALB/c Mice. With 3 Figures.- Role of raf-1 Protein Kinase in IL-3 and GM-CSF-Mediated Signal Transduction.- Identification of Consensus Genes Expressed in Plasmacytomas but Not B Lymphomas. With 2 Figures.- Proliferation of B Cell Precursors in Bone Marrow of Pristane-Conditioned and Malaria-Infected Mice: Implications for B Cell Oncogenesis.- The Human CBLOncogene. With 5 Figures.- LymphoidTumorigenesis by v-abl and BCR-v-abl in Transgenic Mice. With 5 Figures.- Abnormalities of the Immune System Induced by Dysregulated bcl-2 Expression in Transgenic Mice. With 3 Figures.- Growth Regulation to B- Cells : Immortalization.- Immortalization of Primary Murine B Lymphocytes with Oncogene-ContainingRetroviral Vectors. With 2 Figures.- Functionality of Clonal Lymphoid Progenitor Cells Expressing the P210 BCR/ABL Oncogene. With 2 Figures.- Constitutive and Cell Cycle Regulated Expression of c-myc mRNA is Related to the State of Differentiation in Murine B-Lymphoid Tumors. With 3 Figures.- Bcl-2: B Cell Life, Death and Neoplasia.- C-myc Genes in B- Cell Neoplasia.- Binding of NF-KB-like Factors to Regulatory Sequences of the c-myc Gene. With 6 Figures.- Tumorigenesis in Transgenic Mice Expressing the c-mycOncogem with Various Lymphoid Enhancer Elements. With 8 Figures.- Isolation of Normal and Tumor-Specific Pvt-1 cDNA Clones. With 3 Figures.- Expression of c-myc and Pvt-1. With 4 Figures.- Mutational Analysis of the Carboxy-Terminal Casein Kinase II Phosphorylation Site in Human c-myc. With 2 Figures.- The Transforming Activity of PP59C-MYC is Weaker than that of v-myc. With 2 Figures.- Recombination of the c-myc Gene with IgH Enhancer-Sµ Sequences in a Murine Plasmacytoma (DCPC 21) Without Visible Chromosomal Translocations. With 9 Figures.- Downstream Regulatory Elements in the c-myc Gene. With 2 Figures.- DNA Repair in the c-myc Locus. With 2 Figures.- Mechanism of Negative Feed-back Regulation of c-myc Gene Expression in B-Cells and its Inactivation in Tumor Cells. With 5 Figures.- Moloney Murine Leukemia Virus Integration 1060 Base Pairs 5? of c-myc Exon 1 in a Plasmacytoma Without a Chromosomal Translocation. With 2 Figures.- Role of EBV in B-Cell Neoplasia.- Cell Phenotype Dependent Down-regulation of MHC Class I Antigens in Burkitt’s Lymphoma Cells. With 3 Figures.- EBV-Associated B-Cell Lymphomas Following Transfer of Human Peripheral Blood Lymphocytes to Mice with Severe Combined Immune Deficiency With 3 Figures.- Analysis of Epstein-Barr Virus Gene Expression in Lymphomas Derived from Normal Human B Cells Grafted into SCID Mice. With 4 Figures.- Deregulated c-mycGene Expression and Persistence of EBV are Not Sufficient to Maintain the Malignant Phenotype in Burkitt’s Lymphoma x B-Lymphoblastoid Hybrid Cells. With 2 Figures.- Epstein-Barr Virus Latency and Activation in Vivo. With 2 Figures.- Relative Predispositional Effect of a PADPRP Marker Allele in B-Cell and Some Non B-Cell Malignancies. With 4 Figures.- Epstein-Barr Virus Terminal Protein Gene Transcription is Dependent on EBNA 2 Expression and Provides Evidence for Viral Integration into the Host Genome. With 6 Figures.- Genomic Integration as a Novel Mechanism of EBV Persistence. With 2 Figures.- Effect of TGF-beta on the Proliferation of B Cell Lines and on the Immortalisation of B Cells by EBV.


ISBN-13: 9783642758911
Publisher: Springer (Springer Berlin Heidelberg)
Publication date: January, 2012
Pages: 404
Weight: 609g
Availability: POD
Subcategories: Immunology, Microbiology, Oncology
Related books
From the same series


Average Rating